Organisation: AstraZeneca

Each quarter WTR runs a series of pieces highlighting recent Legal Updates that you may have missed. We kick off this new series by looking at cases where the EUIPO was rebuked by the General Court for reaching an erroneous conclusion.

17 April 2023

The General Court underlined the particularly high level of attention of the relevant public when it comes to medicines that have a direct impact on their health.

03 April 2023

QBPC’s selected cases highlight new methods of calculating damages and compensation, the use of big data, and increased cooperation between authorities and businesses.

13 July 2022

The number of new Chinese brands leading the way in global protection exceeds the number of US brands adopting a similar strategy, according to the first ever Clarivate Top 100 New Brands report.

30 June 2022

As brands emerge into the post-pandemic world, Brand Finance’s David Haigh provides a high-level view on a historic year and an informed perspective with which to confront an unpredictable future global landscape

03 March 2022

Apple remains the most valuable brand in the world, with record valuation at more than $355 billion, according to the latest Brand Finance Global 500.

26 January 2022

Featured in Brand trademark tracker

The top 50 owners of the largest active European trademark portfolios together filed 15% fewer marks last year than they did the year before, dropping from 11,427 applications down to 9,902. 

07 July 2021

Featured in Special Report 2021 Q2: Inside in-house operations - how to build world-class trademark functions and portfolios

The top 50 owners of the largest active European trademark portfolios together filed 15% fewer marks last year than they did the year before, dropping from 11,427 applications down to 9,902. 

07 July 2021

As nations begin the roll-out of covid-19 vaccines, there is a risk of bad actors cashing in on the unprecedented demand through dark web marketplaces.

08 January 2021

The big news from Pfizer on its covid-19 vaccine candidate has brought optimism to many this week. In our latest opinion column we consider the brand dimensions of this breakthrough – for Pfizer and the wider pharmaceutical industry. 

11 November 2020